This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Adolor Corporation, Dupont Pharmaceuticals Company. Active years: 1999-2015.
Company Filing History:
Years Active: 1999-2015
Title: David Donald Christ: Innovator in Gastrointestinal and HIV Treatment
Introduction
David Donald Christ is a notable inventor based in Newark, DE (US). He has made significant contributions to the fields of gastrointestinal dysfunction and HIV treatment through his innovative patents. With a total of 2 patents, his work has the potential to impact patient care and treatment methodologies.
Latest Patents
David Christ's latest patents include methods for preventing and treating gastrointestinal dysfunction, particularly postoperative ileus and postpartum ileus. These methods involve administering 4-aryl-piperidine derivatives to patients undergoing surgery or other biological stress. Additionally, he has developed 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones, which are useful as inhibitors of HIV reverse transcriptase. This invention encompasses pharmaceutical compositions and diagnostic kits aimed at treating viral infections.
Career Highlights
Throughout his career, David has worked with prominent companies such as DuPont Pharmaceuticals Company and Adolor Corporation. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
David has collaborated with notable coworkers, including Anthony J Cocuzza and Soo Sung Ko. These partnerships have likely enhanced his research efforts and led to innovative solutions in his field.
Conclusion
David Donald Christ is a distinguished inventor whose work in gastrointestinal and HIV treatment showcases his commitment to advancing medical science. His patents reflect a dedication to improving patient outcomes and addressing critical health challenges.